Modulation of Sarcoplasmic Reticulum Function by Na+/K+Pump Inhibitors with Different Toxicity: Digoxin and PST2744 [(E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride]-Reference-Cited by-同舟云学术

Modulation of Sarcoplasmic Reticulum Function by Na+/K+Pump Inhibitors with Different Toxicity: Digoxin and PST2744 [(E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride]

Published:2004-12-02 Issue:1 Volume:313 Page:207-215
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Rocchetti Marcella,Besana Alessandra,Mostacciuolo Gaspare,Micheletti Rosella,Ferrari Patrizia,Sarkozi Sandor,Szegedi Csaba,Jona Istvan,Zaza Antonio

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. Bers DM (2002a) Ca sources & sinks, in Excitation-Contraction Coupling and Cardiac Contractile Force (Bers DM ed) pp 39–62, Kluwer Academic Publishers, Boston, MA.

2. Bers DM (2002b) Cardiac inotropy and Ca mismanagement, in Excitation-Contraction Coupling and Cardiac Contractile Force (Bers DM ed) pp 273–331, Kluwer Academic Publishers, Boston, MA.

3. Bers DM (2002c) Excitation-contraction coupling, in Excitation-Contraction Coupling and Cardiac Contractile Force (Bers DM ed) pp 203–244, Kluwer Academic Publishers, Boston, MA.

4. Bers DM (2002d) Sarcolemmal Na/Ca exchange and Ca-pump, in Excitation-Contraction Coupling and Cardiac Contractile Force (Bers DM ed) pp 133–160, Kluwer Academic Publishers, Boston, MA.

5. Bers DM (2002e) Ultrastructure, in Excitation-Contraction Coupling and Cardiac Contractile Force (Bers DM ed) pp 1–18, Kluwer Academic Publishers, Boston, MA.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective SERCA2a activator as a candidate for chronic heart failure therapy;Journal of Translational Medicine;2024-01-19

2. Early consequences of the phospholamban mutation PLN‐R14del^+/− in a transgenic mouse model;Acta Physiologica;2024-01-12

3. Selective SERCA2a activator as a candidate for chronic heart failure therapy;2023-11-25

4. Current Targets and Future Directions of Positive Inotropes for Heart Failure;Current Medicinal Chemistry;2023-10-31

5. Early consequences of the phospholamban mutation PLN-R14del^+/-in a transgenic mouse model;2023-04-06